Influenza A M2 Protein Inhibitor global drug patents, pharmaceutical manufacturers and generics

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Impax Labs	RIMANTADINE HYDROCHLORIDE	rimantadine hydrochloride	TABLET;ORAL	076132-001	Aug 30, 2002		RX	No	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Supernus Pharms	OSMOLEX ER	amantadine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	209410-002	Feb 16, 2018		DISCN	Yes	No	8,252,331	⤷ Subscribe	Y			⤷ Subscribe
Supernus Pharms	OSMOLEX ER	amantadine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	209410-003	Feb 16, 2018		DISCN	Yes	No	8,889,740	⤷ Subscribe	Y			⤷ Subscribe
Supernus Pharms	OSMOLEX ER	amantadine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	209410-004	Apr 22, 2020		DISCN	Yes	No	10,213,394	⤷ Subscribe				⤷ Subscribe
Supernus Pharms	OSMOLEX ER	amantadine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	209410-002	Feb 16, 2018		DISCN	Yes	No	10,213,394	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Influenza A M2 Protein Inhibitor Drug Class List